Early research (Phase 1)UnknownNCT04480333
What this trial is testing
Safety, Tolerability and Pharmacokinetics of Inhaled Nanoparticle Formulation of Remdesivir (GS-5734) and NA-831
Who this might be right for
Covid19Corona Virus InfectionSevere Acute Respiratory Syndrome+5 more
Biomed Industries, Inc. 45